Angiosarcoma of the scalp successfully treated with pazopanib

J Am Acad Dermatol. 2014 Jan;70(1):e19-21. doi: 10.1016/j.jaad.2013.08.055. Epub 2013 Oct 29.

Authors

Hajime Tomita¹, Yuta Koike¹, Misachi Asai¹, Fumihide Ogawa¹, Kuniko Abe², Miki Tanioka³, Atsushi Utani⁴

Affiliations

¹ Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
² Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan.
³ Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
⁴ Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Electronic address: utani@nagasaki-u.ac.jp.

PMID: 24176520
DOI: 10.1016/j.jaad.2013.08.055

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Head and Neck Neoplasms / drug therapy*
Hemangiosarcoma / drug therapy*
Humans
Indazoles
Male
Middle Aged
Pyrimidines / therapeutic use*
Scalp*
Skin Neoplasms / drug therapy*
Sulfonamides / therapeutic use*

Substances

Angiogenesis Inhibitors
Indazoles
Pyrimidines
Sulfonamides
pazopanib